Impact of fluorodeoxyglucose PET on the management of esophageal cancer. Nuclear Medicine Communications

dc.contributor.authorSalavati, A.
dc.contributor.authorBasu, Sandip
dc.contributor.authorHeidari, P.
dc.contributor.authorAlavi, A.
dc.date.accessioned2010-08-12T09:04:37Z
dc.date.available2010-08-12T09:04:37Z
dc.date.issued2009
dc.format.extent4147 bytes
dc.format.mimetypetext/html
dc.identifier.urihttp://hdl.handle.net/123456789/3463
dc.language.isoenen
dc.subject18F-fluorodeoxyglucoseen
dc.subjectesophageal neoplasmsen
dc.subjectneoadjuvant therapyen
dc.subjectneoplasm stagingen
dc.subjectpositron emission tomographyen
dc.subjectprognosisen
dc.titleImpact of fluorodeoxyglucose PET on the management of esophageal cancer. Nuclear Medicine Communicationsen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0557.html
Size:
4.05 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections